JP2018523703A5 - - Google Patents

Download PDF

Info

Publication number
JP2018523703A5
JP2018523703A5 JP2018521713A JP2018521713A JP2018523703A5 JP 2018523703 A5 JP2018523703 A5 JP 2018523703A5 JP 2018521713 A JP2018521713 A JP 2018521713A JP 2018521713 A JP2018521713 A JP 2018521713A JP 2018523703 A5 JP2018523703 A5 JP 2018523703A5
Authority
JP
Japan
Prior art keywords
peptide
inflammatory
composition
amino acid
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018521713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018523703A (ja
Filing date
Publication date
Priority claimed from EP15177017.9A external-priority patent/EP3118216A1/en
Priority claimed from EP15177013.8A external-priority patent/EP3118215A1/en
Application filed filed Critical
Priority claimed from PCT/EP2016/067090 external-priority patent/WO2017009484A1/en
Publication of JP2018523703A publication Critical patent/JP2018523703A/ja
Publication of JP2018523703A5 publication Critical patent/JP2018523703A5/ja
Priority to JP2021173218A priority Critical patent/JP7288026B2/ja
Pending legal-status Critical Current

Links

JP2018521713A 2015-07-16 2016-07-18 抗炎症性ペプチドおよびその使用 Pending JP2018523703A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021173218A JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15177017.9A EP3118216A1 (en) 2015-07-16 2015-07-16 Cellular growth and proliferation promoting peptides, and uses thereof
EP15177013.8A EP3118215A1 (en) 2015-07-16 2015-07-16 Anti-inflammatory peptides, and uses thereof
EP15177017.9 2015-07-16
EP15177013.8 2015-07-16
PCT/EP2016/067090 WO2017009484A1 (en) 2015-07-16 2016-07-18 Anti-inflammatory peptides, and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021173218A Division JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用

Publications (2)

Publication Number Publication Date
JP2018523703A JP2018523703A (ja) 2018-08-23
JP2018523703A5 true JP2018523703A5 (enExample) 2019-08-22

Family

ID=56686757

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018521713A Pending JP2018523703A (ja) 2015-07-16 2016-07-18 抗炎症性ペプチドおよびその使用
JP2021173218A Active JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用
JP2023086030A Active JP7739355B2 (ja) 2015-07-16 2023-05-25 抗炎症性ペプチドおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021173218A Active JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用
JP2023086030A Active JP7739355B2 (ja) 2015-07-16 2023-05-25 抗炎症性ペプチドおよびその使用

Country Status (12)

Country Link
US (4) US10463591B2 (enExample)
EP (3) EP3747425A1 (enExample)
JP (3) JP2018523703A (enExample)
KR (3) KR20230132623A (enExample)
CN (2) CN114835784B (enExample)
AU (2) AU2016293129B2 (enExample)
BR (1) BR112018000660A2 (enExample)
CA (1) CA2992378A1 (enExample)
DK (1) DK3322430T3 (enExample)
ES (1) ES2806989T3 (enExample)
MX (2) MX377692B (enExample)
WO (1) WO2017009484A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020504714A (ja) * 2016-12-05 2020-02-13 ニューリタス リミテッド ペプチドｗｋｄｅａｇｋｐｌｖｋを含む組成物
JP7340314B2 (ja) * 2020-01-15 2023-09-07 Tdk株式会社 米に含まれるタンパク質の含有量を測定する方法
KR102354916B1 (ko) * 2020-02-11 2022-01-26 주식회사 쓰리빅스 신규 펩타이드 3ps_i014 및 이의 용도
FR3114744B1 (fr) 2020-10-02 2024-01-05 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer le confort de la peau et/ou des muqueuses et/ou l’apparence des phanères
US20240043474A1 (en) * 2020-12-16 2024-02-08 Ajou University Industry-Academic Cooperation Foundation Anti-inflammatory peptide for preventing or treating atopic dermatitis
CN114478702B (zh) * 2022-04-06 2023-12-12 中南林业科技大学 一种米糠来源短肽及其在治疗皮肤损伤中的应用
CN116375828B (zh) * 2022-09-08 2024-06-04 浙江大学 一种具有抗菌活性的抗菌肽kta及其应用
CN116253782B (zh) * 2022-09-08 2024-06-04 浙江大学 一种广谱抗菌肽ktr及其应用
FR3141066A1 (fr) * 2022-10-24 2024-04-26 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer la matrice extracellulaire du derme de la peau et/ou des muqueuses
CN116491631B (zh) * 2023-05-26 2024-06-25 青岛农业大学 一种预制菜红烧肉及其制备方法
WO2024259556A1 (en) * 2023-06-19 2024-12-26 Viage Therapeutics, Inc. Uses of therapeutic peptides
CN118994314A (zh) * 2023-06-29 2024-11-22 长沙理工大学 一种具有免疫抑制活性的米渣短肽及其应用
WO2025133189A1 (en) * 2023-12-20 2025-06-26 Nuritas Limited Sleep promoting peptides and the use thereof
CN117986337B (zh) * 2024-02-02 2024-08-16 杭州御寿生物科技有限公司 一种提高免疫力的益生菌组合物以及在治疗疾病中的应用
EP4666996A1 (en) * 2024-06-21 2025-12-24 Quiris Healthcare GmbH & Co. KG Composition containing peptides of vegetable origin
CN120590476A (zh) * 2025-08-06 2025-09-05 浙江诺衍生物科技有限公司 一种有助于降血糖的七肽及其应用
CN120574921A (zh) * 2025-08-06 2025-09-02 浙江诺衍生物科技有限公司 一种有助于降血糖的大米肽及其应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
ES2103366T3 (es) 1991-03-07 1997-09-16 Novo Nordisk As Hidrolizado proteico de guisante, metodo para su produccion y su utilizacion.
US5516642A (en) 1992-11-16 1996-05-14 Bristol-Myers Squibb Company Polypeptides derived from major histocompatibility complex Class I antigen
JP2673659B2 (ja) 1994-02-11 1997-11-05 株式会社ホーネンコーポレーション ペプチド
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
IT1313572B1 (it) 1999-07-27 2002-09-09 Enichem Spa Procedimento per la preparazione di epossidi.
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
JP2001335596A (ja) 2000-05-24 2001-12-04 Kenji Sakamoto 新規ペプチド及びその医薬用途
WO2002084250A2 (en) 2001-04-17 2002-10-24 Femtolink Biotechnologies Llc Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
AU2003290582A1 (en) * 2002-11-04 2004-06-07 Florida State University Research Foundation NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale)
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
CN1832755A (zh) 2003-05-23 2006-09-13 佩斯特卡生物医疗实验室公司 使用干扰素治疗严重急性呼吸综合征及其他病毒感染
ES2381359T3 (es) 2003-11-17 2012-05-25 Sederma Composiciones que contienen mezclas de tetrapéptidos y tripéptidos
US20070053845A1 (en) 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
EP1896496B1 (en) 2005-06-29 2012-01-11 Hadasit Medical Research Services & Development Ltd. Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes
US8105572B2 (en) 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
KR100759495B1 (ko) 2006-02-17 2007-09-18 재단법인서울대학교산학협력재단 친수성 생리활성 펩타이드와 소수성 물질을 포함한자기조립 나노구조체
US8343531B2 (en) 2006-04-21 2013-01-01 Meiji Co., Ltd. Composition containing peptide as active ingredient
US9034402B2 (en) 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
EP2840142B1 (en) 2007-06-06 2018-12-26 Monsanto Technology LLC Genes and uses for plant enhancement
JP2010537952A (ja) * 2007-08-24 2010-12-09 マイレクサ ピーティーワイ リミテッド 過敏症反応の調節因子
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
US20120157395A1 (en) * 2009-07-13 2012-06-21 Masahisa Ibuki Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
WO2011122937A1 (en) 2010-03-29 2011-10-06 N.V. Nutricia Pea protein peptides with anti helicobacter pylori activity
ES2397890B1 (es) 2011-03-25 2014-02-07 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
EP2793605A1 (en) * 2011-12-21 2014-10-29 Laboratorios Ordesa, S.L Process for obtaining rice protein hydrolysates useful in the prevention and/or treatment of obesity
EP2897631A4 (en) 2012-08-31 2016-10-05 Univ Virginia Patent Found TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSTICS
BR112015019748A2 (pt) * 2013-02-19 2017-08-22 Danone Sa Peptídeo tendo atividade inibitória da pl e/ou pla2, produto alimentício adequado para o tratamento da obesidade e/ou estresse oxidativo, e, uso de streptococcus thermophilus cncm i-2776 e/ou streptococcus thermophilus cncm i-1630 e/ou lactobacillus paracasei subsp paracasei cncm i-4270
WO2016090252A1 (en) 2014-12-04 2016-06-09 Mary Kay Inc. Topical skin care composition comprising trifluoroacetyl tripeptide-2
US20170183386A1 (en) 2015-07-16 2017-06-29 Nuritas Limited Peptides, and uses thereof

Similar Documents

Publication Publication Date Title
JP2018523703A5 (enExample)
JP2018015005A5 (enExample)
JP2018503668A5 (enExample)
Huang et al. Metallacyclic assembly of interlocked superstructures
Bakhru et al. Oral delivery of proteins by biodegradable nanoparticles
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
JP2017528444A5 (enExample)
JP2017528419A5 (enExample)
JP2010215657A5 (enExample)
HRP20161677T1 (hr) Pegilirani fab protiv amiloida beta
JP2016512248A5 (enExample)
HRP20221021T1 (hr) T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02
JP2006502741A5 (enExample)
JP2011515499A5 (enExample)
JP2010513526A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
HRP20231437T1 (hr) Il-15 i il-15ralpha sushi domena na temelju modulokina
FI3065763T4 (fi) Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten
JP2016506727A5 (enExample)
JP2016502515A5 (enExample)
JP2018500385A5 (enExample)
MY194925A (en) Composition of fish skin collagen peptides and use thereof as a drug
WO2014151200A3 (en) Guanylate cyclase receptor agonists combined with other drugs
HRP20160547T1 (hr) Pegilirani apelin i njegova upotreba
SI3068796T1 (en) Calcitonin mimetics for the treatment of diseases and disorders